usa — track Congress Laws

Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026

HR 10369 · In committee · last action September 14, 2026

Plain-language summary not yet available.

Sponsor

Ryan Mackenzie (R-PA)

Associated votes

No votes recorded against this bill yet — vote coverage is a work in progress.